Role of Angiotensin II in Injury-Induced Neointima Formation in Rats

Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. Firs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 1991-10, Vol.18 (4 Suppl II), p.II-60-II-64
Hauptverfasser: Osterrieder, Wolfgang, Miiller, Rita K.M, Powell, Jerry S, Clozel, Jean-Paul, Hefti, Fridolin, Baumgartner, Hans R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page II-64
container_issue 4 Suppl II
container_start_page II-60
container_title Hypertension (Dallas, Tex. 1979)
container_volume 18
creator Osterrieder, Wolfgang
Miiller, Rita K.M
Powell, Jerry S
Clozel, Jean-Paul
Hefti, Fridolin
Baumgartner, Hans R
description Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. First, the balloon model was used to compare the effects of continuous infusion of Ang II, with and without concurrent converting enzyme inhibition by cilazapril; second, the effects of the orally active nonpeptidic Ang II receptor antagonist DuP 753 were analyzed. Morphometric analysis was performed at 14 days after balloon injury. Animals that received continuous infusion of Ang II (0.3 μ/min/rat) were found to have significantly greater neointima formation in response to balloon injury than controls. Animals treated with cilazapril (10 mg/kg/day) had markedly reduced neointima formation, but in animals receiving infusion of Ang II, treatment with cilazapril did not suppress development of neointimal lesions. In the second group of experiments, DuP 753 (10 mg/kg twice daily) was as effective to prevent neointima formation as cilazapril. These data sapport the conclusions that converting enzyme inhibition prevents neointima formation after vascular injury through inhibition of Ang II generation.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72132281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72132281</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1831-6d0ca8fc4bc9d6b50e254607249c204238b0f3d879138b7a9b12a4fd9e7be9a13</originalsourceid><addsrcrecordid>eNotUF1LwzAUDaLMOf0JQp98C-SrH3kc02lhKAwF30ra3LrONJlJy9i_N2W7D-feyzmc-3GF5jRlAos049doTqgUWFL6fYvuQtgTQoUQ-QzNaME5Z-kcPW-dgcS1ydL-dG4AGzqblGUyod2P_oRLq8cGdPIOrrND16tk7Xyvhs7ZSbVVQ7hHN60yAR4ueYG-1i-fqze8-XgtV8sNPsR5FGeaNKpoG1E3Umd1SoClIiM5E7JhRDBe1KTlusgljWWuZE2ZEq2WkNcgFeUL9HT2PXj3N0IYqr4LDRijLLgxVDmjnLFiEj5ehGPdg64OPu7tT9Xl7MiLM390ZgAffs14BF_tQJlhV5EYgmUFpjL-LjYUT0D5P5UsYuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72132281</pqid></control><display><type>article</type><title>Role of Angiotensin II in Injury-Induced Neointima Formation in Rats</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete - AutoHoldings</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Osterrieder, Wolfgang ; Miiller, Rita K.M ; Powell, Jerry S ; Clozel, Jean-Paul ; Hefti, Fridolin ; Baumgartner, Hans R</creator><creatorcontrib>Osterrieder, Wolfgang ; Miiller, Rita K.M ; Powell, Jerry S ; Clozel, Jean-Paul ; Hefti, Fridolin ; Baumgartner, Hans R</creatorcontrib><description>Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. First, the balloon model was used to compare the effects of continuous infusion of Ang II, with and without concurrent converting enzyme inhibition by cilazapril; second, the effects of the orally active nonpeptidic Ang II receptor antagonist DuP 753 were analyzed. Morphometric analysis was performed at 14 days after balloon injury. Animals that received continuous infusion of Ang II (0.3 μ/min/rat) were found to have significantly greater neointima formation in response to balloon injury than controls. Animals treated with cilazapril (10 mg/kg/day) had markedly reduced neointima formation, but in animals receiving infusion of Ang II, treatment with cilazapril did not suppress development of neointimal lesions. In the second group of experiments, DuP 753 (10 mg/kg twice daily) was as effective to prevent neointima formation as cilazapril. These data sapport the conclusions that converting enzyme inhibition prevents neointima formation after vascular injury through inhibition of Ang II generation.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>PMID: 1833325</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Angiotensin II - physiology ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Biphenyl Compounds - pharmacology ; Carotid Arteries - drug effects ; Carotid Arteries - pathology ; Cell Division - drug effects ; Cilazapril ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - pathology ; Endothelium, Vascular - physiology ; Imidazoles - pharmacology ; Losartan ; Male ; Pyridazines - pharmacology ; Rats ; Regeneration - drug effects ; Tetrazoles - pharmacology</subject><ispartof>Hypertension (Dallas, Tex. 1979), 1991-10, Vol.18 (4 Suppl II), p.II-60-II-64</ispartof><rights>1991 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1833325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Osterrieder, Wolfgang</creatorcontrib><creatorcontrib>Miiller, Rita K.M</creatorcontrib><creatorcontrib>Powell, Jerry S</creatorcontrib><creatorcontrib>Clozel, Jean-Paul</creatorcontrib><creatorcontrib>Hefti, Fridolin</creatorcontrib><creatorcontrib>Baumgartner, Hans R</creatorcontrib><title>Role of Angiotensin II in Injury-Induced Neointima Formation in Rats</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. First, the balloon model was used to compare the effects of continuous infusion of Ang II, with and without concurrent converting enzyme inhibition by cilazapril; second, the effects of the orally active nonpeptidic Ang II receptor antagonist DuP 753 were analyzed. Morphometric analysis was performed at 14 days after balloon injury. Animals that received continuous infusion of Ang II (0.3 μ/min/rat) were found to have significantly greater neointima formation in response to balloon injury than controls. Animals treated with cilazapril (10 mg/kg/day) had markedly reduced neointima formation, but in animals receiving infusion of Ang II, treatment with cilazapril did not suppress development of neointimal lesions. In the second group of experiments, DuP 753 (10 mg/kg twice daily) was as effective to prevent neointima formation as cilazapril. These data sapport the conclusions that converting enzyme inhibition prevents neointima formation after vascular injury through inhibition of Ang II generation.</description><subject>Angiotensin II - physiology</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Biphenyl Compounds - pharmacology</subject><subject>Carotid Arteries - drug effects</subject><subject>Carotid Arteries - pathology</subject><subject>Cell Division - drug effects</subject><subject>Cilazapril</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - pathology</subject><subject>Endothelium, Vascular - physiology</subject><subject>Imidazoles - pharmacology</subject><subject>Losartan</subject><subject>Male</subject><subject>Pyridazines - pharmacology</subject><subject>Rats</subject><subject>Regeneration - drug effects</subject><subject>Tetrazoles - pharmacology</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotUF1LwzAUDaLMOf0JQp98C-SrH3kc02lhKAwF30ra3LrONJlJy9i_N2W7D-feyzmc-3GF5jRlAos049doTqgUWFL6fYvuQtgTQoUQ-QzNaME5Z-kcPW-dgcS1ydL-dG4AGzqblGUyod2P_oRLq8cGdPIOrrND16tk7Xyvhs7ZSbVVQ7hHN60yAR4ueYG-1i-fqze8-XgtV8sNPsR5FGeaNKpoG1E3Umd1SoClIiM5E7JhRDBe1KTlusgljWWuZE2ZEq2WkNcgFeUL9HT2PXj3N0IYqr4LDRijLLgxVDmjnLFiEj5ehGPdg64OPu7tT9Xl7MiLM390ZgAffs14BF_tQJlhV5EYgmUFpjL-LjYUT0D5P5UsYuQ</recordid><startdate>199110</startdate><enddate>199110</enddate><creator>Osterrieder, Wolfgang</creator><creator>Miiller, Rita K.M</creator><creator>Powell, Jerry S</creator><creator>Clozel, Jean-Paul</creator><creator>Hefti, Fridolin</creator><creator>Baumgartner, Hans R</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199110</creationdate><title>Role of Angiotensin II in Injury-Induced Neointima Formation in Rats</title><author>Osterrieder, Wolfgang ; Miiller, Rita K.M ; Powell, Jerry S ; Clozel, Jean-Paul ; Hefti, Fridolin ; Baumgartner, Hans R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1831-6d0ca8fc4bc9d6b50e254607249c204238b0f3d879138b7a9b12a4fd9e7be9a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Angiotensin II - physiology</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Biphenyl Compounds - pharmacology</topic><topic>Carotid Arteries - drug effects</topic><topic>Carotid Arteries - pathology</topic><topic>Cell Division - drug effects</topic><topic>Cilazapril</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - pathology</topic><topic>Endothelium, Vascular - physiology</topic><topic>Imidazoles - pharmacology</topic><topic>Losartan</topic><topic>Male</topic><topic>Pyridazines - pharmacology</topic><topic>Rats</topic><topic>Regeneration - drug effects</topic><topic>Tetrazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Osterrieder, Wolfgang</creatorcontrib><creatorcontrib>Miiller, Rita K.M</creatorcontrib><creatorcontrib>Powell, Jerry S</creatorcontrib><creatorcontrib>Clozel, Jean-Paul</creatorcontrib><creatorcontrib>Hefti, Fridolin</creatorcontrib><creatorcontrib>Baumgartner, Hans R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Osterrieder, Wolfgang</au><au>Miiller, Rita K.M</au><au>Powell, Jerry S</au><au>Clozel, Jean-Paul</au><au>Hefti, Fridolin</au><au>Baumgartner, Hans R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Angiotensin II in Injury-Induced Neointima Formation in Rats</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>1991-10</date><risdate>1991</risdate><volume>18</volume><issue>4 Suppl II</issue><spage>II-60</spage><epage>II-64</epage><pages>II-60-II-64</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><abstract>Angiotensin converting enzyme inhibition markedly suppresses neointima formation in response to balloon catheter-induced vascular injury of the rat carotid artery. To determine whether this effect was mediated through the vasoactive peptide angiotensin II (Ang II), two approaches were followed. First, the balloon model was used to compare the effects of continuous infusion of Ang II, with and without concurrent converting enzyme inhibition by cilazapril; second, the effects of the orally active nonpeptidic Ang II receptor antagonist DuP 753 were analyzed. Morphometric analysis was performed at 14 days after balloon injury. Animals that received continuous infusion of Ang II (0.3 μ/min/rat) were found to have significantly greater neointima formation in response to balloon injury than controls. Animals treated with cilazapril (10 mg/kg/day) had markedly reduced neointima formation, but in animals receiving infusion of Ang II, treatment with cilazapril did not suppress development of neointimal lesions. In the second group of experiments, DuP 753 (10 mg/kg twice daily) was as effective to prevent neointima formation as cilazapril. These data sapport the conclusions that converting enzyme inhibition prevents neointima formation after vascular injury through inhibition of Ang II generation.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>1833325</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 1991-10, Vol.18 (4 Suppl II), p.II-60-II-64
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_miscellaneous_72132281
source MEDLINE; American Heart Association Journals; Journals@Ovid Complete - AutoHoldings; EZB-FREE-00999 freely available EZB journals
subjects Angiotensin II - physiology
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Animals
Biphenyl Compounds - pharmacology
Carotid Arteries - drug effects
Carotid Arteries - pathology
Cell Division - drug effects
Cilazapril
Endothelium, Vascular - drug effects
Endothelium, Vascular - pathology
Endothelium, Vascular - physiology
Imidazoles - pharmacology
Losartan
Male
Pyridazines - pharmacology
Rats
Regeneration - drug effects
Tetrazoles - pharmacology
title Role of Angiotensin II in Injury-Induced Neointima Formation in Rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T23%3A39%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Angiotensin%20II%20in%20Injury-Induced%20Neointima%20Formation%20in%20Rats&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Osterrieder,%20Wolfgang&rft.date=1991-10&rft.volume=18&rft.issue=4%20Suppl%20II&rft.spage=II-60&rft.epage=II-64&rft.pages=II-60-II-64&rft.issn=0194-911X&rft.eissn=1524-4563&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72132281%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72132281&rft_id=info:pmid/1833325&rfr_iscdi=true